Skip to main content

Table 1 Patients' characteristics

From: log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

  

All patients

Q I

Q II

Q III

Q IV

Q V

P

n

 

585

117

117

117

117

117

 

log (TG). HDL-C -1

 

0.053

0.032

0.042

0.050

0.060

0.082

~

age

years

65 (12)

67 (12)

67 (12)

63 (12)

65 (12)

63 (10)

0.0083

smoking *

%

36/64

41/59

44/56

40/60

31/69

24/76

0.0010

ethanol

U.week-1

16 (23)

21 (25)

19 (21)

16 (24)

14 (21)

11 (25)

0.0093

LT physical activity **

%

60/40

55/45

53/47

58/42

67/33

68/32

0.0072

LT screen watching ***

hr.day-1

3.1 (1.8)

2.7 (1.8)

2.8 (1.6)

2.8 (1.6)

3.0 (1.5)

4.0 (2.2)

<0.0001

BMI

kg.m-2

28.8 (5.1)

26.5 (4.9)

27.9 (4.5)

29.2 (5.0)

30.1 (5.0)

30.4 (5.3)

<0.0001

waist circumference

cm

105 (13)

98 (13)

103 (11)

105 (12)

109 (12)

109 (13)

<0.0001

conicity index

m2.kg-1

1.35 (0.08)

1.33 (0.08)

1.35 (0.07)

1.36 (0.08)

1.37 (0.07)

1.37 (0.08)

0.0002

fat mass

%

27.4 (6.2)

25.0 (6.7)

26.9 (6.0)

27.5 (6.5)

28.6 (5.5)

28.8 (5.6)

<0.0001

visceral fat

0 - 30

14 (5)

12 (5)

13 (4)

14 (5)

15 (4)

15 (5)

<0.0001

liver steatosis

%

68

50

61

69

72

83

<0.0001

insulinaemia

pmol.l-1

113 (77)

80 (47)

103 (67)

122 (98)

125 (83)

132 (71)

<0.0001

HOMA S

%

53 (34)

69 (39)

61 (40)

50 (30)

49 (30)

39 (23)

<0.0001

HOMA product (B × S)

%

28.5 (18.2)

35.7 (21.6)

31.1 (16.2)

26.7 (15.8)

26.7 (16.2)

22.5 (16.5)

<0.0001

(B × S) loss rate

%.yr-1

1.29 (0.45)

1.15 (0.50)

1.18 (0.33)

1.38 (0.52)

1.28 (0.40)

1.44 (0.39)

<0.0001

metabolic syndrome

%

76

36

67

83

95

97

<0.0001

metabolic syndrome score

1/5 to 5/5

3.4

2.3

2.9

3.5

4.0

4.4

<0.0001

statin/fibrate

%

54/21

49/9

51/11

59/21

57/16

56/46

NS/<0.0001

macroangiopathy

%

40

29

38

44

40

48

0.006

   CAD

%

29

15

32

32

31

33

0.0097

   TIA/stroke

%

9

5

5

10

10

13

0.0129

   PAD

%

12

15

13

11

8

14

NS

  1. Results are expressed as means (1 SD) or proportions (%). *: never vs. former/current; **: no leisure-time (LT) physical activity (PA) vs. any level of LT-PA. CAD: coronary artery disease; BMI: body mass index; HOMA B & S: beta-cell function and insulin sensitivity from homeostatic model assessment; PAD: peripheral artery disease; Q: quintile; TIA: transient ischaemic attack. NS: not significant.